Impact of atrial fibrillation on the no-flow phenomenon during primary percutaneous coronary intervention  

作　　者：LIN Ming-duan GUO Guan-hua HUANG Zi-ming CHEN Yu PENG Chang LING Guang-jiao ZHANG Yan-qing 林明锻;郭观华;黄自明;陈瑜;彭畅;凌观娇;张燕清(Cardiology department,Central People's Hospital of Zhanjiang,Zhanjiang 524000,Guangdong,China)

机构地区：[1]Cardiology department,Central People's Hospital of Zhanjiang,Zhanjiang 524000,Guangdong,China

出　　处：《South China Journal of Cardiology》2020年第2期98-103,共6页岭南心血管病杂志（英文版）

摘　　要：Background Atrial fibrillation(AF)is reported to be associated with worse flow in patients with the treatment of coronary thrombolysis. However,few studies investigated the impact of atrial fibrillation on the noreflow phenomenon in ST-segment elevation myocardial infarction(STEIMI)patients undergoing primary percutaneous intervention(PCI). Methods 1163 STEMI patients undergoing primary PCI from Jan 2013 to Dec2019 were enrolled. Atrial fibrillation was diagnosed based on the electrocardiogram’s findings. Patients with a TIMI flow rate less than 3 were considered to have no-reflow. Factors related to the no-reflow phenomenon was analyzed by the logistic regression analysis. Results 158 patients were in the AF group and 1005 patients were in the non-AF group. The AF group had a significantly higher occurrence of cardiogenic shock(11.4% vs. 5.6%,P<0.001),and in-hospital mortality(9.5% vs. 3.1%,P<0.001)than the non-AF group. The multivariate analysis showed that AF was an independent risk factor for the no-reflow phenomenon after primary PCI(OR:2.11,95% CI:1.27-3.88,P=0.014). Conclusions STEMI patients with AF would have higher in-hospital adverse events and no-reflow phenomenon than though without AF.

关 键 词：NO-REFLOW ST-segment elevation atrial fibrillation 

分 类 号：R541.75[医药卫生—心血管疾病]